State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis

M Sollini, M Kirienko, F Gelardi, F Fiz, N Gozzi… - European Journal of …, 2021 - Springer
Introduction Fibroblast activation protein-α (FAPα) is overexpressed on cancer-associated
fibroblasts in approximately 90% of epithelial neoplasms, representing an appealing target …

Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga] Ga-nanobody: From bench to bedside

L Li, X Lin, L Wang, X Ma, Z Zeng, F Liu, B Jia… - European Journal of …, 2023 - Springer
Purpose An accurate diagnosis of colorectal carcinoma (CRC) can assist physicians in
developing reasonable therapeutic regimens, thereby significantly improving the patient's …

Noninvasive biomarkers of colorectal cancer: role in diagnosis and personalised treatment perspectives

G Pellino, G Gallo, P Pallante… - Gastroenterology …, 2018 - Wiley Online Library
Colorectal cancer (CRC) is the third leading cause of cancer‐related deaths worldwide. It
has been estimated that more than one‐third of patients are diagnosed when CRC has …

[HTML][HTML] Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update

K Kitajima, M Nakajo, H Kaida… - Nagoya journal of …, 2017 - ncbi.nlm.nih.gov
Positron emission tomography/computed tomography (PET/CT) integrated with 2-[18 F]
fluoro-2-deoxy-D-glucose (FDG) is a useful tool for acquisition of both glucose metabolism …

Imaging in colorectal cancer: progress and challenges for the clinicians

E Van Cutsem, HMW Verheul, P Flamen, P Rougier… - Cancers, 2016 - mdpi.com
The use of imaging in colorectal cancer (CRC) has significantly evolved over the last twenty
years, establishing important roles in surveillance, diagnosis, staging, treatment selection …

Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment

KD Bosch, S Chicklore, GJ Cook, AR Davies… - European journal of …, 2020 - Springer
Aim 18-fluorodeoxyglucose positron emission tomography-computed tomography (FDG PET-
CT) is valuable in the management of patients with oesophageal cancer, but a role in gastric …

Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer …

Y Touchefeu, C Bailly, E Frampas, T Eugène… - European Journal of …, 2021 - Springer
Introduction This pilot study evaluated the imaging performance of pretargeted
immunological positron emission tomography (immuno-PET) using an anti …

Prognostic significance of parameters from pretreatment 18F-FDG PET in hepatocellular carcinoma: a meta-analysis

DW Sun, L An, F Wei, L Mu, XJ Shi, CL Wang… - Abdominal …, 2016 - Springer
Purpose The prognostic value of 18 F-deoxyglucose positron emission tomography (18 F-
FDG PET) on hepatocellular carcinoma (HCC) remains inconclusive. This study aims to …

[HTML][HTML] Brazilian Gastric Cancer Association guidelines (part 1): an update on diagnosis, staging, endoscopic treatment and follow-up

LC Barchi, MFKP Ramos, OK Yagi… - … Brasileiros de Cirurgia …, 2020 - SciELO Brasil
ABSTRACT Background: The II Brazilian Consensus on Gastric Cancer by the Brazilian
Gastric Cancer Association (ABCG) was recently published. On this occasion, several …

The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers—Review of the Literature

A Secerov Ermenc, B Segedin - Cancers, 2023 - mdpi.com
Simple Summary Gastrointestinal cancers represent a major burden in oncology worldwide.
As radiotherapy is a cornerstone of the treatment strategies, accurate treatment planning is …